The challenge
A rare-disease pharmaceutical company needed expert interviews with clinicians who had used a new gene therapy outside a clinical trial. Only a handful of prescribers exist in each market, and the study ran in three phases mixing client-supplied lists with independent recruitment of hospital pharmacists.
Our approach
We combined client lists with free-found recruitment and handled every contact to clinical-grade standards.
- Engaged client-listed haematologists and independently sourced hospital pharmacists by phase
- Scheduled 45 to 60-minute web-assisted telephone interviews around clinical rotas
- Provided native-language moderation, simultaneous translation and transcription in non-English markets
- Ran adverse-event-aware processes and strict confidentiality throughout
The results
- Three study phases delivered across seven markets
- Independent recruitment unlocked pharmacists the client list could not reach
- Consistent multilingual delivery kept findings comparable across countries
Client project. Client details are anonymised.
